Litcius/Paper detail

Human embryonic stem cell-derived organoid retinoblastoma reveals a cancerous origin

Hui Liu, Yan Zhang, You-You Zhang, Yan-Ping Li, Zi-Qi Hua, Chang-Jun Zhang, Kun‐Chao Wu, Fulong Yu, Yaru Zhang, Jianzhong Su, Zi‐Bing Jin

2020Proceedings of the National Academy of Sciences141 citationsDOIOpen Access PDF

Abstract

gene. These organoid Rbs exhibit properties highly consistent with Rb tumorigenesis, transcriptome, and genome-wide methylation. Single-cell sequencing analysis suggests that Rb originated from ARR3-positive maturing cone precursors during development, which was further validated by immunostaining. Notably, we found that the PI3K-Akt pathway was aberrantly deregulated and its activator spleen tyrosine kinase (SYK) was significantly up-regulated. In addition, SYK inhibitors led to remarkable cell apoptosis in cancerous organoids. In conclusion, we have established an organoid Rb model derived from genetically engineered hESCs in a dish that has enabled us to trace the cell of origin and to test novel candidate therapeutic agents for human Rb, shedding light on the development and therapeutics of other malignancies.

Topics & Concepts

OrganoidRetinoblastomaEmbryonic stem cellCarcinogenesisBiologyStem cellCancer researchCell biologyCell of originCellCellular differentiationMolecular biologyGeneticsCancerGeneOcular Oncology and TreatmentsRetinal Development and DisordersCancer-related Molecular Pathways
Human embryonic stem cell-derived organoid retinoblastoma reveals a cancerous origin | Litcius